Cargando…

Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer

SIMPLE SUMMARY: Only about 4% of thyroid nodules are carcinomas and require surgery. Fine-needle aspiration cytology is the most accurate tool to distinguish benign from malignant thyroid nodules, however it yields an indeterminate result in about 30% of the cases, posing diagnostic and prognostic d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marotta, Vincenzo, Bifulco, Maurizio, Vitale, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345070/ https://www.ncbi.nlm.nih.gov/pubmed/34359686 http://dx.doi.org/10.3390/cancers13153785

Ejemplares similares

A Benign Medullary Thyroid Cancer
por: Pishdad, Reza, et al.
Publicado: (2022)

Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
por: Cavedon, Elisabetta, et al.
Publicado: (2017)

Comparison of Natural Course between Thyroid Cancer Nodules and Thyroid Benign Nodules
por: Yun, Kyun-Jin, et al.
Publicado: (2019)

Benign and malignant thyroid nodules with autoimmune thyroiditis
por: Kassi, Georgia N., et al.
Publicado: (2022)

Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
por: Miasaki, Fabíola Yukiko, et al.
Publicado: (2020)

Significance of radiofrequency ablation in large solid benign thyroid nodules
por: Lin, Yan, et al.
Publicado: (2022)

Elastography Evaluation of Benign Thyroid Nodules in Patients Affected by Hashimoto's Thyroiditis
por: Cappelli, Carlo, et al.
Publicado: (2015)

Different Threshold of Malignancy for RAS-like Thyroid Tumors Causes Significant Differences in Thyroid Nodule Practice
por: Kakudo, Kennichi
Publicado: (2022)

Radiofrequency Ablation of Benign Thyroid Nodules and Recurrent Thyroid Cancers: Consensus Statement and Recommendations
por: Na, Dong Gyu, et al.
Publicado: (2012)

A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology
por: Kloos, Richard T., et al.
Publicado: (2016)

Diagnosis of medullary thyroid cancer
por: Marchisotta, Stefania, et al.
Publicado: (2009)

Natural Course of Benign Thyroid Nodules
por: Kim, Kyung Won
Publicado: (2013)

Efficacy of levothyroxine on benign thyroid nodule
por: Bayani, Mohammadali, et al.
Publicado: (2012)

Indeterminate Thyroid Nodules With RAS Mutations Have Higher Rates of Malignancy When Multiple Non-Cystic Nodules or Irregular Borders Are Present
por: Bernuy, Mario Carlos C Rivera, et al.
Publicado: (2021)

Genetic susceptibility to hereditary non-medullary thyroid cancer
por: Kamani, Tina, et al.
Publicado: (2022)

Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma
por: Bo, Xiao-Wan, et al.
Publicado: (2020)

Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients
por: Caleo, Alessia, et al.
Publicado: (2013)

Thermal Ablation for Benign Thyroid Nodules: Radiofrequency and Laser
por: Baek, Jung Hwan, et al.
Publicado: (2011)

Treatment of advanced medullary thyroid cancer
por: Smit, Johannes
Publicado: (2013)

An Introduction to Managing Medullary Thyroid Cancer
por: de Groot, Jan Willem, et al.
Publicado: (2006)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management
por: Marotta, Vincenzo, et al.
Publicado: (2022)

Familial non-medullary thyroid cancer: a critical review
por: Capezzone, M., et al.
Publicado: (2020)

Genetic and Epigenetic of Medullary Thyroid Cancer
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Prognostic significance and optimal cutoff of age in medullary thyroid cancer
por: Qu, Ning, et al.
Publicado: (2016)

Significance of LINC02082 and LOC105369812 in differentiating papillary thyroid cancer from benign nodules
por: Xu, Jingya, et al.
Publicado: (2023)

Serum Adiponectin and Progranulin Level in Patients with Benign Thyroid Nodule or Papillary Thyroid Cancer
por: Kwon, Hyemi, et al.
Publicado: (2020)

Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC)
por: Diquigiovanni, Chiara, et al.
Publicado: (2021)

Thyroid nodules and evaluation of thyroid cancer risk
por: Hoang, Jeremy
Publicado: (2015)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

Role of vandetanib in the management of medullary thyroid cancer
por: Brassard, Maryse, et al.
Publicado: (2012)

Advanced medullary thyroid cancer: pathophysiology and management
por: Ferreira, Carla Vaz, et al.
Publicado: (2013)

How I treat medullary thyroid cancer
por: Kiesewetter, B., et al.
Publicado: (2021)

Significance of chromogranin A and synaptophysin in medullary thyroid carcinomas
por: Tomita, Tatsuo
Publicado: (2021)

SAT-585 Presence of Metastatic Medullary Thyroid Cancer without a Distinct Thyroid Nodule: A Diagnostic Challenge
por: Xhikola, Majlinda, et al.
Publicado: (2019)

Risk Factors Associated with Benign and Malignant Thyroid Nodules in Autoimmune Thyroid Diseases
por: Lima, Priscila Carneiro Moreira, et al.
Publicado: (2013)

Italian Guidelines for the Management of Non-Functioning Benign and Locally Symptomatic Thyroid Nodules
por: Papini, Enrico, et al.
Publicado: (2023)

Targeted Treatment of Differentiated and Medullary Thyroid Cancer
por: Bales, Shannon R., et al.
Publicado: (2011)

Elastography in Distinguishing Benign from Malignant Thyroid Nodules
por: Colakoglu, Bulent, et al.
Publicado: (2016)

Mucin in benign thyroid nodules: treatment related change or not?
por: Handra-Luca, Adriana
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_17595jnq8cc0qb0ksf0nncqi39